OFORTA
Dead / Cancelled — Cancelled — Section 8 (as of 20 Jan 2017)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 77570872
- Registration number
- 3803959
- Mark type
- Stylized text
- Filed
- 16 Sept 2008
- Published for opposition
- 10 Feb 2009
- Registered
- 15 Jun 2010
- Attorney of record
- Karen Lim
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical products and preparations for use in the treatment of cancer, cancerous conditions, leukemia, lymphoma, and tumors
Owner
- SANOFI-AVENTIS U.S. LLC, BRIDGEWATER, NJ, US
- SANOFI-AVENTIS U.S. LLC, BRIDGEWATER, NJ, US
- Xanthus Pharmaceuticals, Inc., Cambridge, MA, US
- Xanthus Pharmaceuticals, Inc., Cambridge, MA, US
Prosecution history
- 08 Jan 2020 — REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
- 10 Dec 2019 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 20 Jan 2017 — CANCELLED SEC. 8 (6-YR)
- 15 Jun 2010 — REGISTERED-PRINCIPAL REGISTER
- 12 May 2010 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 11 May 2010 — LAW OFFICE REGISTRATION REVIEW COMPLETED
- 11 May 2010 — ASSIGNED TO LIE
- 03 May 2010 — ASSIGNED TO EXAMINER
- 30 Apr 2010 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 12 Apr 2010 — STATEMENT OF USE PROCESSING COMPLETE
- 06 Apr 2010 — USE AMENDMENT FILED
- 06 Apr 2010 — TEAS STATEMENT OF USE RECEIVED
- 19 Mar 2010 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 18 Mar 2010 — SOU EXTENSION 2 GRANTED
- 12 Feb 2010 — SOU EXTENSION 2 FILED